ONO NT 012
Latest Information Update: 16 Jul 1998
At a glance
- Originator Ono Pharmaceutical
- Class Analgesics; Prostaglandins; Small molecules
- Mechanism of Action Prostaglandin E1 antagonists; Prostaglandin E3 agonists; Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 1998 No-Development-Reported for Pain in Japan (Unknown route)
- 03 Aug 1995 New profile
- 03 Aug 1995 Preclinical development for Pain in Japan (Unknown route)